Assenagon Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-969
| Closed | -$206K | – | 1371 |
|
|
2024
Q3 | $206K | Sell |
969
-4,862
| -83% | -$1.03M | ﹤0.01% | 1289 |
|
|
2024
Q2 | $1.63M | Sell |
5,831
-7,127
| -55% | -$2M | ﹤0.01% | 950 |
|
|
2024
Q1 | $3.46M | Sell |
12,958
-6,124
| -32% | -$1.64M | 0.01% | 681 |
|
|
2023
Q4 | $4.42M | Sell |
19,082
-23,294
| -55% | -$5.39M | 0.01% | 640 |
|
|
2023
Q3 | $6.19M | Sell |
42,376
-424,390
| -91% | -$62M | 0.02% | 494 |
|
|
2023
Q2 | $108M | Sell |
466,766
-49,822
| -10% | -$11.5M | 0.37% | 38 |
|
|
2023
Q1 | $125M | Buy |
516,588
+392,145
| +315% | +$95M | 0.44% | 39 |
|
|
2022
Q4 | $36.1M | Buy |
124,443
+115,234
| +1,251% | +$33.4M | 0.13% | 141 |
|
|
2022
Q3 | $598K | Hold |
9,209
| – | – | ﹤0.01% | 1030 |
|
|
2022
Q2 | $659K | Buy |
+9,209
| New | +$659K | ﹤0.01% | 1128 |
|
|
2021
Q2 | – | Sell |
-16,098
| Closed | -$1.88M | – | 1283 |
|
|
2021
Q1 | $1.88M | Buy |
+16,098
| New | +$1.88M | 0.01% | 694 |
|